U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07047807) titled 'PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma' on June 24.
Brief Summary: This study aims to refine and pilot test PDAC-PATHWAYS, a digital informational and supportive care app for patients who are initiating neoadjuvant therapy for pancreatic ductal adenocarcinoma (PDAC).
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
PDAC - Pancreatic Ductal Adenocarcinoma
Intervention:
BEHAVIORAL: PDAC-PATHWAYS
A digital app for patients initiating neoadjuvant therapy for PDAC
OTHER: Usual Care
Routine treatment
Recruit...